Another form of therapy, which has already been successfully used in earlier viral diseases, such as severe acute respiratory syndrome coronavirus (SARS) [10] or middle east respiratory syndrome (MERS) [11], is the transfusion of convalescent plasma (CP) from persons who have recovered from COVID-19 [12, 13]. The gene discussed is CP; the disease is COVID-19.